Cite
MLA Citation
JS Smolen et al.. “AB0766 Secukinumab provides sustained remission and low disease activity related to disease activity index for psoriatic arthritis (DAPSA): 2 year results from the future 2 study.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 1323–1324. http://access.bl.uk/ark:/81055/vdc_100135134678.0x000060